Filing excerpt
On March 3, 2026, we entered into a settlement agreement with Arbutus and Genevant to resolve all patent infringement litigation pending worldwide.
Source: Autobound Signal API · 106 signals tracked for Moderna · updated
Get Moderna's live signals in Claude or ChatGPT, or by API
What changed at Moderna this week? Use Autobound signals for modernatx.com.The company resolved all worldwide patent infringement litigation with Arbutus and Genevant, incurring a $950 million accrual. This material event significantly impacted Q1 financials and cash flow, highlighting the high cost of intellectual property disputes.
Filing excerpt
On March 3, 2026, we entered into a settlement agreement with Arbutus and Genevant to resolve all patent infringement litigation pending worldwide.
What this signalsFilings often name leadership changes, deals and spending plans.
Competitors
sec-10qlitigationMaterialGet every 10-Q signal for Moderna and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Moderna this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/fb57b7f7-3841-4934-87c0-c2a5c330fdb0 returns this record as JSON. POST /v1/companies/enrich returns every signal for modernatx.com.
{
"signal_id": "fb57b7f7-3841-4934-87c0-c2a5c330fdb0",
"signal_type": "sec-10q",
"signal_subtype": "litigationMaterial",
"detected_at": "2026-05-05T08:48:22.452+00:00",
"company": {
"name": "Moderna",
"domain": "modernatx.com"
},
"data": {
"detail": "The company resolved all worldwide patent infringement litigation with Arbutus and Genevant, incurring a $950 million accrual. This material event significantly impacted Q1 financials and cash flow, highlighting the high cost of intellectual property disputes.",
"metrics": {
"timeframe": "current_quarter",
"dollar_context": "Litigation settlement accrual",
"dollar_millions": 950
},
"summary": "Settled patent litigation with Arbutus and Genevant for $950M in Q1 2026.",
"excerpts": "On March 3, 2026, we entered into a settlement agreement with Arbutus and Genevant to resolve all patent infringement litigation pending worldwide.",
"relevance": 0.95,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285226000060/mrna-20260331.htm",
"filing_date": "2026-05-01",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/31",
"sales_relevance": "Legal tech opportunity",
"signal_category": "risk",
"competitors_mentioned": [
"Arbutus Biopharma Corporation",
"Genevant Sciences GmbH"
]
}
}
curl https://signals.autobound.ai/v1/signals/fb57b7f7-3841-4934-87c0-c2a5c330fdb0 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"modernatx.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.